Latest posts tagged with #CARTtherapy on Bluesky
Who's up at BATS?
Myra Dada (Manalis & Hemann): “Investigating Cell Stiffness as a Determinant of CAR T Efficacy in B-ALL”
Connie Wang (Collins & Edelman): “Nanoengineering Materials to Probe Tissue-Implant Interactions”
https://be.mit.edu/our-community/seminars/
#CARTtherapy #ramanspectroscopy
❓¿Qué cánceres puede tratar la terapia CAR-T?
Hoy se usa principalmente para algunos cánceres de la sangre, como:
🔬 Leucemia
🔬 Linfoma
🔬 Mieloma múltiple
🎥 Mira el video para saber más.
#CARTTherapy #Immunotherapy #Oncology #DengYueMed
How effective is CAR-T therapy in real-world oncology practice?
Our latest case study explores clinical outcomes and expert perceptions from healthcare professionals in the US & Europe.
Read the research:
www.sperresearch.com/Case-Studies...
#CancerResearch #CARTTherapy
Researchers show dual-target CD19/CD22 #CARTTherapy plus ASCT achieves durable survival in #TP53-mutated r/r aggressive #BNHL, offering curative potential with consistent long-term safety and paving the way for next-gen #immunotherapies.
#OpenAccess in #STTT: doi.org/10.1038/s413...
🚀 Want smarter insights into the CAR-T therapy market in 2026?
Discover how CARTnavigator helps pharma and biotech companies track pipelines, forecast growth, and stay ahead of competition.
👉 Read now:
articlescad.com/the-complete...
#CARTnavigator #CARTTherapy
From our in-depth interview on "Top Advanced Medical Treatments in China for International Patients":
This clip focus on "The TRUTH About China's Cheap Healthcare"
Full article: zurl.co/pVnXM
Follow us for more short insights!
#CARTtherapy #ChinaMedicalTourism
#Gilead #celltherapy #Arcellx #GileadSciences #celltherapies #cancer #oncology #CARTtherapy #multiplemyeloma #Anitocel #CARexpression #BCMAtarget #BCMAdirectedCARTs #relapsedmultiplemyeloma #refractorymultiplemyeloma #iMMagine1study #multiplemyelomapatients #BCMAbindertechnology
zurl.co/iWAbv
From our in-depth interview on "CAR-T Therapy in China":
This clip focus on "Is THIS the Lupus Cure We’ve Been Waiting For?"
Full article: zurl.co/jrhad
Follow us for more short insights!
#CARTTherapy #CancerTreatment #CART #ChinaMedicalTourism
From our in-depth interview on "CAR-T Therapy in China":
This clip focus on "China’s Cancer Breakthroughs: 2026"
Full article: zurl.co/jsduW
Follow us for more short insights!
#CARTTherapy #CancerTreatment #CART #MedicalConcierge #MedBridgeNZ #ChinaMedicalTourism
From our in-depth interview on "CAR-T Therapy in China":
This clip focus on "Cancer Treatment: Weeks → 1.5 Days?!"
Full article: zurl.co/U9EJt
Follow us for more short insights!
#CARTTherapy #MedicalConcierge #MedBridgeNZ #MedicalTourismChina #ChinaMedicalTourism
From our in-depth interview on "CAR-T Therapy in China":
This clip focus on "The New King of Oncology? (It's Not Who You Think)"
Full article: zurl.co/fAOvO
Follow us for more short insights!
#CARTTherapy #CancerTreatment #CART #China #ChinaMedicalTourism
Advanced CAR-T therapy shouldn't be out of reach.
Through Medical Tourism China, patients are accessing CD7-knockout & CLDN18.2 therapies at GoBroad Healthcare for ~85% less than US prices.
Read the report: zurl.co/tomKz
#CARTTherapy #China #ChinaMedicalTourism
CAR-T Therapy in China: The 2026 Reality.
Cost: $120k - $170k (vs $400k+ in US)
Innovation: Leading the world in Gastric & Liver cancer trials
Access: Faster entry via "Dual-Track" regulation
Read the guide: zurl.co/StwIg
#CARTTherapy #CART #China #ChinaMedicalTourism
Could CAR-T therapy change everything for people with severe AiArthritis disease? CAR-T therapy is showing remarkable results in clinical trials and could soon move faster toward availability.
🎙️ Listen to the full episode: zurl.co/GEwaN
#CarTtherapy #AiArthritis #AiArthritisTreatments
RD118, a new anti-GPRC5D #CARTtherapy, may be an effective therapeutic option in heavily pretreated cases of #MultipleMyeloma #MMsm, including those relapsing after BCMA therapy, according to phase I research resulting in a durable ORR of 94.4%: https://ow.ly/FQGQ50XXspe
#HemeSky #MyelomaSky
#BristolMyersSquibb has taken #CARTtherapy of #bloodcancers into new territory, after getting #FDAapproval for Breyanzi as a treatment for relapsed or refractory #marginalzonelymphoma (MZL).
pharmaphorum.com/news/bmss-br...
Navigating Shanghai Ruijin Hospital as an expat? From CAR-T therapy to VIP suites, our new guide covers it all.
Read more: zurl.co/qffEc
#Ruijin #Shanghai #Hospital #MedicalConcierge #GlobalHealth #CARTTherapy #MedBridgeNZ #MedicalTourismChina #ChinaMedicalTourism
#haematology #NICE #NHS #leukaemiaCART #Autolus #leukaemia #CARTtherapy #NHSroutinecommissioning #Aucatzyl #BcellALL #acutelymphoblasticleukaemia #relapsedALL #refractoryALL #Bcellprecursoracutelymphoblasticleukaemia #ALL #NICEfinaldraftguidance #HTA #FELIXtrial #NICEguidance
zurl.co/h6OwD
A groundbreaking study published in Cell reveals a stunning 83% drug-free remission rate for neurological autoimmune conditions using CAR-T Therapy.
Read full story:zurl.co/phT6w
#CARTTherapy #AutoimmuneDisease #MedicalTourismChina #ChinaMedicalTourism
Hundreds of people with a rare and aggressive form of #leukaemia will be able to access a #CARTtherapy developed by #UK biotech #Autolus after it was recommended for routine commissioning by the #NHS.
Can CAR-T be optimized? Study details high-titer γ-retroviral vectors for mouse T cells. #CARTTherapy #Immunotherapy
www.rimpacts.com/rd/p?c=10073... 📄DOI: doi.org/10.1002/cpz1...
Gilead and Kite Showcase Continued Progress in Transforming Blood Cancer Care With New Cell Therapy Data at ASH 2025
stellanews.life/technology_c...
#CARTtherapy #BloodCancer #Gilead #KitePharma #AnitoCel #MultipleMyeloma #DLBCL #ASH2025 #CellTherapy #iMMagine1
From our in-depth interview on "Stem Cell Therapy China - A Breakthrough for Pulmonary Fibrosis":
This clip focus on "15% LUNG BOOST! New Hope for Lung Fibrosis!"
Full article: zurl.co/xzldE
#MedicalTourismChina #CARTtherapy #CancerTreatment #Oncology
China is leading a revolution in CAR-T cancer therapy—at a fraction of the global cost.
This is a breakthrough for Medical Tourism in China.
Learn how in our new guide: zurl.co/19E5w #CARTtherapy #CancerTreatment #MedBridgeNZ #Oncology #HealthTech #MedicalTourismChina
Sexual health after transplant or CAR-T is rarely discussed—but it matters.
Dr. Catalina Lawsin and survivor Loriana Hernández-Aldama break the silence about pain, desire, and rediscovering intimacy after treatment.
🎥 Link in comments
#BMTInfoNet #SexualHealth #SurvivorshipCare #CARTTherapy
CRISPR + CAR-T + strategic cytokine delivery = chef's kiss 👨🍳💋
Kah Min Yap is engineering safer cancer immunotherapy by making IL-12 and IL-2 hit ONLY the tumors. No systemic toxicity, just targeted destruction.
This is the future, folks!
buff.ly/YFF4c4Z
#CARTTherapy #CRISPR #SmartImmunotherapy
Managing infection after transplant & CAR-T therapy.
Dr. Gowri Satyanarayana (Northside Hospital Atlanta) covers prevention, vaccines & GVHD care.
🎥 Watch: bmtinfonet.org/video/managi...
#BMTInfoNet #Transplant #CARTTherapy #InfectionControl
🌟 #HICARA® (CD19 CAR-T Therapy) 🌟
Breakthrough treatment for relapsed/refractory large B-cell lymphoma ( #r/rLBCL).
💊 Pioneering CAR-T therapy improving patient outcomes in China.
🔗 Learn more: dengyuemed.com/product/hica...
#HongKongDrugWholesaleDistributor
#HongKongDengYueMedicine
#CARTTherapy
Considering CAR-T therapy? China offers world-class treatment at a fraction of the US cost. Our 2025 guide for international patients details everything from costs to top hospitals
Full guide:zurl.co/IlDHT
#CARTTherapy #CancerTreatment #MedicalTourismChina #Lymphoma
🧫 The CAR-T Cell Therapy Market projected to hit USD 7.2 Bn by 2032 with 14.5% CAGR — advancing immunotherapy. 🔗 www.einpresswire.com/article/7778... #CARTTherapy #Oncology #CellTherapy
